Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)
- Resource Type
- Article
- Source
- JTO Clinical and Research Reports; April 2024, Vol. 5 Issue: 4
- Subject
- Language
- ISSN
- 26663643